欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/0358/001
药品名称Levodopa/carbidopa retard 100/25 mg
活性成分
    • cabidopa (as monohydrate) 25.0 mg
    • levodopa carbidopa (as monohydrate) 100.0 mg
剂型Modified-release tablet
上市许可持有人Hexal AG Industriestrasse 25 D-83607 Holzkirchen
参考成员国 - 产品名称Netherlands (NL)
互认成员国 - 产品名称
    • Germany (DE)
    • Italy (IT)
    • Sweden (SE)
许可日期2002/11/18
最近更新日期2025/01/24
药物ATC编码
    • N04BA02 levodopa and decarboxylase inhibitor
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Article 4.8(a)(iii), first paragraph
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase